HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clemens Muehlan Selected Research

daridorexant

1/2022Driving Performance after Bedtime Administration of Daridorexant, Assessed in a Sensitive Simulator.
11/2021Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairment.
10/2021Effect of Liver Cirrhosis on the Pharmacokinetics, Metabolism, and Tolerability of Daridorexant, A Novel Dual Orexin Receptor Antagonist.
8/2021Impact of Daridorexant, a Dual Orexin Receptor Antagonist, on Cardiac Repolarization Following Bedtime Dosing: Results from a Thorough QT Study Using Concentration-QT Analysis.
12/2020Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects.
11/2020The dual orexin receptor antagonist daridorexant does not affect the pharmacokinetics of the BCRP substrate rosuvastatin.
11/2020Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders.
3/2020Pharmacokinetics and Pharmacodynamics of the Dual Orexin Receptor Antagonist Daridorexant in Japanese and Caucasian Subjects.
1/2020Clinical pharmacology of the dual orexin receptor antagonist ACT-541468 in elderly subjects: Exploration of pharmacokinetics, pharmacodynamics and tolerability following single-dose morning and repeated-dose evening administration.
1/2019Multiple-dose clinical pharmacology of ACT-541468, a novel dual orexin receptor antagonist, following repeated-dose morning and evening administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Clemens Muehlan Research Topics

Disease

8Sleep Initiation and Maintenance Disorders (Insomnia)
01/2022 - 01/2019
3Sleep Wake Disorders
10/2021 - 03/2020
2Sleepiness
12/2020 - 01/2019
1Body Weight (Weight, Body)
11/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2021
1Fibrosis (Cirrhosis)
10/2021
1Dizziness (Lightheadedness)
12/2020
1Fatigue
12/2020
1Headache (Headaches)
12/2020
1Breast Neoplasms (Breast Cancer)
11/2020

Drug/Important Bio-Agent (IBA)

10daridorexantIBA
01/2022 - 01/2019
8Orexin Receptor AntagonistsIBA
01/2022 - 03/2020
2Pharmaceutical PreparationsIBA
01/2020 - 01/2019
1CreatinineIBA
11/2021
1Ethanol (Ethyl Alcohol)IBA
12/2020
1seltorexantIBA
11/2020
1suvorexantIBA
11/2020
1Proteins (Proteins, Gene)FDA Link
11/2020
1lemborexantIBA
11/2020
1Hallucinogens (Psychedelics)IBA
01/2019